CD8A and neoplasm: RT/TMZ/PL combinations resumed ROS level by resetting ROSgen/ROSsca, exacerbated oxidative stress-induced cell death, enhanced inflammatory and immune responses (including IFN TAMs, CD8+ T cells), thus converted “cold” tumor microenvironment to “hot” and produced curable efficacy (Fig. 8).